Viewing nowCita 100 mg (Sitagliptin Phosphate Hydrate)
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 201504251 · Approved 2015.06.30 · Insurance code 643507330
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be used alone or in combination with other medications to effectively improve blood glucose levels and support health management.
This drug is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This drug may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. (See Precautions for Use, section 5, General Precautions.) Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function before treatment with this drug and periodically during treatment is recommended. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This drug may be administered regardless of the timing of dialysis.
This medication is used to treat diabetes and helps to control blood sugar levels. However, serious allergic reactions may occur while taking this medication; if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, discontinue use immediately and consult a medical professional. Severe side effects like pancreatitis have been reported. If symptoms such as abdominal pain, nausea, or vomiting occur, stop taking this medication immediately and visit a hospital. This medication should not be used in patients with type 1 diabetes or those with diabetic ketoacidosis, and should be avoided by individuals with hypersensitivity to this medication or its components. Patients with impaired kidney function may require dose adjustments due to increased drug concentration, so if there is a kidney condition, consult a doctor. Additionally, this medication contains a dye called Yellow 5, so individuals allergic to this component should take caution. During treatment, hypoglycemic symptoms may occur, so it is particularly important to monitor blood sugar changes when used with other hypoglycemic agents or insulin. Severe joint pain or skin blistering symptoms may appear, and if these occur, notify a physician immediately. Use of this medication is not recommended for pregnant or nursing women, and safety in children and adolescents under 18 years of age has not been established. Elderly patients may have decreased kidney function, so it is important to have periodic kidney function tests before and during use of this medication. In case of overdose, standard emergency treatment should be administered, and blood dialysis may be required to remove the drug. It is safe to adhere to the precautions mentioned above while taking this medication, and it is advised to consult medical personnel immediately if unusual symptoms occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure. The storage temperature should be kept between 1 and 30 degrees Celsius at room temperature.
Orange, round, convex, film-coated tablets on both sides
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Sitagliptin Phosphate Hydrate 32.13mg
Tablet · Prescription medication
Jong Kundang Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 32.125mg
Tablet · Prescription medication
Sinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.